Skip to main content
EyeGene,Inc logo

EyeGene,Inc — Investor Relations & Filings

Ticker · 185490 ISIN · KR7185490000 KO Professional, scientific and technical activities
Open in API
Filings indexed 314 across all filing types
Latest filing 2019-09-16 Capital/Financing Update
Country KR South Korea
Listing KO 185490

About EyeGene,Inc

https://eyegene.co.kr/en/

EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.

Recent filings

Filing Released Lang Actions
전환가액의조정(제1회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing from a Korean company (Eutilex/Eyegene) regarding the adjustment of the conversion price of convertible bonds (CB). This type of disclosure, which details changes to the capital structure and conversion terms of debt instruments, falls under the 'Capital/Financing Update' category. It is not a report publication announcement, but rather the primary disclosure of the financial event itself.
2019-09-16 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '아이진(주)' (Eyegene Inc.) covering the period from January 1, 2019, to June 30, 2019. It contains detailed corporate information, financial data, capital structure, and management reports, which are characteristic of an interim or quarterly financial report. It is not a mere announcement or certification, as it provides substantive financial and operational details. H1 2019
2019-08-23 Korean
기타경영사항(자율공시)(2019년 연결대상 적용에 따른 반기보고서 제출 기한 연장)
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement from the company '아이진' regarding the extension of the submission deadline for its 2019 semi-annual report due to the adoption of consolidated financial statements. It is a brief notification (under 5,000 characters) informing the public about a reporting timeline change, which fits the definition of a general regulatory announcement or a report publication/timing notice.
2019-08-16 Korean
전환가액의조정(제1회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (CB) issued by the company 'Eyegene'. It details the change in conversion price from 16,100 KRW to 12,800 KRW due to a decline in market price, which directly impacts the company's capital structure and potential share dilution. This falls under the category of capital and financing updates.
2019-06-14 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '아이진(주)' (Eyegene Inc.) covering the period from 2019-01-01 to 2019-03-31. It contains detailed corporate information, capital structure changes, and financial data, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-15 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) meeting (기업설명회). It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an event rather than the actual presentation slides or a comprehensive financial report, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2019-05-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.